Diclofenac epolamine

Butaprost is a structural analog of prostaglandin E2 (PGE2) with good selectivity for the EP2 receptor subtype. Butaprost has frequently been used to pharmacologically define the EP receptor expression profile of various human and animal tissues and

Butaprost is a structural analog of prostaglandin E2 (PGE2) with good selectivity for the EP2 receptor subtype. Butaprost has frequently been used to pharmacologically define the EP receptor expression profile of various human and animal tissues and

11-deoxy Prostaglandin E1 (11-deoxy PGE1) is a synthetic analog of PGE1 . Early reports show that it is a selective agonist for the EP2 receptor but effective at much higher concentrations than PGE2. However, later studies show that it is a

11-deoxy Prostaglandin E1 (11-deoxy PGE1) is a synthetic analog of PGE1 . Early reports show that it is a selective agonist for the EP2 receptor but effective at much higher concentrations than PGE2. However, later studies show that it is a

Biochem/physiol Actions ALW-II-41-27 is an RG-25 (RG25) structural analog that exhibits enhanced type II kinase inhibitor activity against ephrin type-A receptor 2/EphA2/ECK (IC50 = 11 nM vs 770 nM with NG25) by targeting the ATP-binding pocket

Epinephrine Auto-Injector, 0.3mg, 2/pk (Rx) (US Only, Excluding IN and ND) (Separate PO Required: Product is Non-Returnable)

Anti-ESPN espin, 25ul UN 1687 6.1 PG2

AX 048, ethyl 4-[(2-oxohexadecanoyl)amino]butanoate, is a PLA|2|(Phospholipase A|2|) and PGE|2|(Prostaglandin E|2|) inhibitor. PLAs are known to play a role in various cellular processes such as host defense, phospholipid digestion and metabolism,

AX 048, ethyl 4-[(2-oxohexadecanoyl)amino]butanoate, is a PLA|2|(Phospholipase A|2|) and PGE|2|(Prostaglandin E|2|) inhibitor. PLAs are known to play a role in various cellular processes such as host defense, phospholipid digestion and metabolism,

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the